February 19, 2014 | Israeli company Neuronix, which developed an innovative treatment for Alzheimer’s disease, has raised $5.5 million from a private investor. Neuronix’s treatment is a combination of magnetic stimulation of the brain and cognitive training.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments